Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-03-02 @ 8:03 PM
Study NCT ID:
NCT03326193
Status:
COMPLETED
Last Update Posted:
2025-07-31
First Post:
2017-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
Sponsor:
Tesaro, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-12
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-10
First Submit QC Date:
None
Study First Post Date:
2017-10-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-12-20
Results First Submit QC Date:
None
Results First Post Date:
2022-01-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-30
Last Update Post Date:
2025-07-31
Last Update Post Date Type:
ACTUAL